Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Forest_Laboratories
|
| gptkbp:acquisitionYear |
2014
|
| gptkbp:focus |
gptkb:diabetes
drug development gastrointestinal disorders |
| gptkbp:foundedIn |
2008
|
| gptkbp:founder |
gptkb:Fred_Eshelman
|
| gptkbp:headquartersLocation |
gptkb:Morrisville,_North_Carolina,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Furiex Pharmaceuticals
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableProduct |
gptkb:eluxadoline
|
| gptkbp:status |
defunct
|
| gptkbp:stockSymbol |
gptkb:FURX
|
| gptkbp:bfsParent |
gptkb:Fred_Eshelman
|
| gptkbp:bfsLayer |
6
|